This article is more than 5 years old. Information may no longer be current.

BRCA research center to present second annual prize

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Mary-Claire King, PhD, will receive the second annual Basser Global Prize from the University of Pennsylvania's Basser Research Center for BRCA.

King, American Cancer Society research professor of genetics and medicine at the University of Washington, discovered the BRCA1 gene.

She will deliver the keynote address at the annual Basser Research Center for BRCA Symposium, which will be held May 11-12, 2015. She will receive the Basser Trophy, a $10,000 cash prize, and $200,000 in unrestricted support for innovative BRCA1/BRCA2-related research.

“We’re very excited to honor Dr. King’s accomplishments in BRCA-related research,” Susan Domchek, MD, executive director of the Basser Research Center and the Basser Professor of Medicine in Penn’s Abramson Cancer Center, said in a press release. “The identification of BRCA1 was the first critical step in work to improve outcomes for individuals with inherited susceptibility to breast cancer. Supporting research projects that are similarly devoted to the prevention and treatment of BRCA-related cancers is a primary mission of the Basser Center.”

In 1990, King demonstrated that a single gene on chromosome 17q21 — which she named BRCA1 — was responsible for breast and ovarian cancer in many families. King’s current research focuses on the identification and characterization of critical genes that play a role in the development of conditions such as breast and ovarian cancer, schizophrenia, and hearing loss.